Over 20 years combined health care management experience; gathering, analyzing and reporting market and product information with emphasis in pharmaceutical, biotech, medical education/communication, patient, provider and payer environments.
Proven ability to provide analytics, insight and strategic solutions for complex business opportunities. Provide qualified data / information to ensure confidence associated with decisive actions. Interacted with numerous pharmaceutical companies and many functions within the organizations (e.g., C levels, R&D, Marketing, MSL, Regulatory, and Compliance). Incorporate market research (insights) with other real-world evidence (analytics) to develop programs / models for analyzing options.
Comprehensive claims data source utilization; CRM administrator (SalesForce.com, Veeva, Workamajig, Hubspot, and Synergistix).
Novartis (E. Hanover, NJ) : 6-mo contract Oct 2020 - Mar 2021
Liaison between US commercial and India offshore (Hyderabad) NBS CONEXTS
Managed all inquiries with LAAD data set (IQVIA apld); incl. the KPIs: Time-to-Fill, Persistency, Adherence, Abandonment, and Reject by Gender via Alteryx and QlikView /data lake, cloud.
Managed inquiries with HCOS (DDD MD) via SAS (Enterprise Guide)/servers
Assisted team with Xolair Performance Trackers (Sales Force Effectiveness) via Excel and PowerPoint.
Fidia Pharma Inc., LLC (Florham Park, NJ) Ful-time Mar 2019 – May 2020
Sales Operations Analyst – (Medical Device Data Analytics)
Reported to the President and led IT/Data/Analytics for 60+ sales reps, 6 district managers, the MSL team and payer/KAMs.
Migrated CRM from Synergistix to Veeva Vault and Open Data with BOAST LMS/ data management; distributor data sets for buy ‘n bill.
Managed claims data (MMIT/PlanTrak) dashboard development (DDD/Xponent) via Tableau for Targeting, Incentive Compensation models, Market Assessment, and Technology reviews. Assisted in launches: Hymovis, CartiJoint FORTE, and TriLURON.
Bristol Myers Squibb (Summit, NJ) 6-mo contract & renewal Dec 2017 – Nov 2018
Sr. Pharma Consultant (Data Enablement & Reporting/ Strategic Planning team)
Evaluate overall value associated with investment and utilization of Symphony and IQVIA data sources. Some of the opportunities and associated business cases included:
•Multiple myeloma landscape – treatment patterns, treatment duration, drug trends
•Drug usage – early adopters, patient demographics, forecasting
•Fulfillment (GPOs, SPP, mail order, ACOs, LTC)
Led programs / projects to realize the following successes:
•Fedratinib launch preparation (Specialty Pharmacy, data aggregator selection)
•Improved depth and accuracy of transactions carried out by 300+ Hematology/Oncology field sales reps/ District Sales Managers, and 80 Clinical Nurse Consultants.
•Implemented data governance (stewardship) practice across commercial IT
•Enabled “qualified” field inquiries for specialty REMS products in Oncology/multiple myeloma: Revlimid, Pomalyst, and Abraxane (breast cancer)
•Added competitive intelligence for claims (IQVIA, SHA, McKesson, Truven) / EHR integration, claims de-identification, affiliations, incentive compensation, market access into Veeva applications
•Developed Tableau “factbooks” i.e., dashboards, C-level reports, used to assess efficacy of previous business decisions, and spawn additional actions
QPharma / Veeva (Morris Plains, NJ) Full-time Mar 2014 – Nov 2017 (4 years)
Director, Business Development (Advanced Analytics agency)
Responsible for expanding footprint and future opportunities associated with stakeholder (KOL) management, encounter-based, patient-centric, network mapping, and rare-disease, diagnosis accelerator platforms. Consulted with Medical affairs (MSLs) and Brand teams, championed KOL influence networks to new market-access stakeholders (ACOs, medical home, patient advocacy groups, and IDNs). Integrated data from IQVIA, SHA, client-specific files to develop analysis of best-fit opportunities for respective client (Novo Nordisk, AstraZeneca, and Novartis). Led analysis and implementation projects for following areas:
•Patient drug spend – copay, OOPs, total drug spend
•Support product launches – oncology, rare disease, orphan drug
•Formulary benefit design – Tier structure, managed-care pull through
•Enhance speaker engagement & non-personal promotion (NPP)
•Sales targeting optimization – understanding referral patterns, modify call planning, and incentive compensation(territory profitability)
Emron (Wayne, NJ) Full-time Sep 2007 – Feb 2014 (7+ years)
Director, Sales & Marketing (Managed Markets agency)
Responsibilities included formulating strategic business initiatives for payer, provider, patient custom market research to allow commercial teams to better understand and approach their customers (Plans, Specialty), leveraging various methodologies:
•All Qual/ Quant methodologies, incl. conjoint studies, discrete choice, SPSS
•Market access contracting and reimbursement/ pricing strategies, HEOR
•Push- and pull-through programs for inline and launch (phase I - IV) products
Cultivated new clients and new lines of revenue by evaluating market information, for multi-year, sole-sponsored publications to establish client leadership position in target disease states and/or in depth studies include:
Kline & Company (Little Falls, NJ) Full-time Jan 2001 - Aug 2007 (7+ years)
Engagement Manager (Management Consulting)
Led organizational change/business transformation analysis in the healthcare sectors, includng oncology, by developing custom and syndicated market research and value-chain market assessments (benchmarking, competitive intelligence, pending M&A, manufacturing economics). Client and trade association presentations. Fingertip formulary, InterStudy.
Seton Hall University (S. Orange, NJ) – MBA, Finance
U of Tennessee, Statistics College (Knoxville, TN) – Design of Experiments (Six Sigma)
Tufts University (Medford, MA) - BS, Chemical Engineering